NABLab is interested in applying the technologies developed pertaining to the exquisite detection of nucleic acids to clinically relevant diagnostics problems, particularly in cancer and in infectious diseases. In both, assays for acquired drug resistances are of particular interest. NABLab is collaborating with several groups, both in academia and in industry, on specific applications.